Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.

[Factors associated with high exposure to psychotropic drugs in a Montreal catchment epidemiological area].

Perreault M, Djemaâ-Samia MT, Fleury MJ, Touré el H, Mitchell E, Caron J.

Sante Ment Que. 2013 Spring;38(1):259-78. French.

PMID:
24337000
2.

Typology of sleep medication users and associated mental health and substance use from a Montreal epidemiological study.

Perreault M, Mitchell E, Touré el H, Fleury MJ, Caron J.

J Popul Ther Clin Pharmacol. 2014;21(2):e233-45. Epub 2014 Jun 9.

PMID:
25134745
3.

[Psychotropic drug use and correspondence with psychiatric diagnoses in the mental health in the general population survey].

Grolleau A, Cougnard A, Bégaud B, Verdoux H.

Encephale. 2008 Sep;34(4):352-9. doi: 10.1016/j.encep.2007.07.011. Epub 2007 Dec 26. French.

PMID:
18922237
4.

[Psychotropic medications use in Spain. Results of the ESEMeD-Spain study].

Codony M, Alonso J, Almansa J, Vilagut G, Domingo A, Pinto-Meza A, Fernández A, Serrano-Blanco A, Márquez M, Haro JM.

Actas Esp Psiquiatr. 2007 Sep;35 Suppl 2:29-36. Spanish.

PMID:
18264867
5.

[Polypharmacy in psychiatric patients as an alternative to limited mental health resources].

de las Cuevas C, Sanz EJ, de la Fuente JA, Cueto M.

Actas Esp Psiquiatr. 2005 Mar-Apr;33(2):81-6. Spanish.

PMID:
15768314
6.

Risk of low bone mineral density associated with psychotropic medications and mental disorders in postmenopausal women.

Bolton JM, Targownik LE, Leung S, Sareen J, Leslie WD.

J Clin Psychopharmacol. 2011 Feb;31(1):56-60. doi: 10.1097/JCP.0b013e3182075587.

PMID:
21192144
7.

Past and present socioeconomic circumstances and psychotropic medication: a register-linkage study.

Mauramo E, Lallukka T, Laaksonen M, Martikainen P, Rahkonen O, Lahelma E.

J Epidemiol Community Health. 2012 Dec;66(12):1143-51. doi: 10.1136/jech-2011-200036. Epub 2012 Apr 21.

PMID:
22523341
8.

Investigating geographic variation in use of psychotropic medications among youth in child welfare.

Leslie LK, Raghavan R, Hurley M, Zhang J, Landsverk J, Aarons G.

Child Abuse Negl. 2011 May;35(5):333-42. doi: 10.1016/j.chiabu.2011.01.012.

PMID:
21620160
9.

National trends in psychotropic medication polypharmacy in office-based psychiatry.

Mojtabai R, Olfson M.

Arch Gen Psychiatry. 2010 Jan;67(1):26-36. doi: 10.1001/archgenpsychiatry.2009.175.

PMID:
20048220
10.

[Duty militaries' consumption of psychotropic drugs in 2005].

Desjeux G, Aspar AM, Colonna-d'Istria E, Raude D, Birioukoff M, Balaire C, Codaccioni A, Thevenin-Garron V.

Encephale. 2009 Jun;35(3):249-55. doi: 10.1016/j.encep.2008.07.001. Epub 2008 Sep 27. French.

PMID:
19540411
11.

Correlates of psychotropic drug use in the elderly compared to adults aged 18-64: results from the Quebec Health Survey.

Préville M, Hébert R, Boyer R, Bravo G.

Aging Ment Health. 2001 Aug;5(3):216-24.

PMID:
11575060
12.

[Psychotropic drug use and mental psychiatric disorders in France; results of the general population ESEMeD/MHEDEA 2000 epidemiological study].

Gasquet I, Nègre-Pagès L, Fourrier A, Nachbaur G, El-Hasnaoui A, Kovess V, Lépine JP.

Encephale. 2005 Mar-Apr;31(2):195-206. French.

PMID:
15959446
13.

[Modifications in psychotropic drug use patterns in a Southern Brazilian city].

Rodrigues MA, Facchini LA, Lima MS.

Rev Saude Publica. 2006 Feb;40(1):107-14. Epub 2006 Jan 4. Portuguese.

15.

[Common mental disorders and the use of psychoactive drugs: the impact of socioeconomic conditions].

Lima MC, Menezes PR, Carandina L, Cesar CL, Barros MB, Goldbaum M.

Rev Saude Publica. 2008 Aug;42(4):717-23. Epub 2008 Jun 27. Portuguese.

16.

Psychotropic drug utilization in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project.

Alonso J, Angermeyer MC, Bernert S, Bruffaerts R, Brugha TS, Bryson H, de Girolamo G, Graaf R, Demyttenaere K, Gasquet I, Haro JM, Katz SJ, Kessler RC, Kovess V, Lépine JP, Ormel J, Polidori G, Russo LJ, Vilagut G, Almansa J, Arbabzadeh-Bouchez S, Autonell J, Bernal M, Buist-Bouwman MA, Codony M, Domingo-Salvany A, Ferrer M, Joo SS, Martínez-Alonso M, Matschinger H, Mazzi F, Morgan Z, Morosini P, Palacín C, Romera B, Taub N, Vollebergh WA; ESEMeD/MHEDEA 2000 Investigators, European Study of the Epidemiology of Mental Disorders (ESEMeD) Project.

Acta Psychiatr Scand Suppl. 2004;(420):55-64.

PMID:
15128388
17.

Epidemiology of psychotropic drug use in Rio de Janeiro, Brazil: gaps in mental illness treatments.

Quintana MI, Andreoli SB, Moreira FG, Ribeiro WS, Feijo MM, Bressan RA, Coutinho ES, Mari JJ.

PLoS One. 2013 May 14;8(5):e62270. doi: 10.1371/journal.pone.0062270. Print 2013.

18.

Use of psychotropic medication groups in people with severe mental illness and stressful childhood experiences.

Schneeberger AR, Muenzenmaier K, Castille D, Battaglia J, Link B.

J Trauma Dissociation. 2014;15(4):494-511. doi: 10.1080/15299732.2014.903550.

PMID:
24678974
19.

Use and cost of psychotropic drugs among recipients with autism in a state Medicaid fee-for-service programme.

Khanna R, Jariwala K, West-Strum D.

J Intellect Disabil Res. 2013 Feb;57(2):161-71. doi: 10.1111/j.1365-2788.2012.01563.x. Epub 2012 Apr 4.

PMID:
22471524
20.

Few middle-aged women with severe mental symptoms use psychotropic drugs: the Women's Health in Lund Area (WHILA) study.

Rundberg J, Lidfeldt J, Nerbrand C, Samsioe G, Romelsjö A, Ojehagen A.

Scand J Public Health. 2005;33(5):384-91.

PMID:
16267887

Supplemental Content

Support Center